MarketInOut Stock Screener Log In | Sign Up

Aprea Therapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 11/20/2026 16:00
Aprea Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization5.74 mln
Float11.46 mln
Earnings Date03/30/2027

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-36.58
Highly reliable

1-Year Forecast

3.30
Transformational upside

Relative Strength

2 / 100
Severely lagging

Pre-Tax Margin

-423,879%
Severely loss-making

ROE

-49.93
Deeply negative

Business Description

Aprea Therapeutics is a Pennsylvania-based company working to bring new cancer treatments to patients. The company is currently testing two experimental drugs in early-stage clinical trials ? one targeting a protein called WEE1 and another targeting ATR ? both designed to fight solid tumors by disrupting the way cancer cells repair their DNA. Its approach focuses on exploiting specific weaknesses in cancer cells to slow or stop tumor growth.

Key Fundamentals

EPS-0.57
ROE-49.93
ROIC-1,443
ROA-44.35
EBITDA, mln-14.12
EV / EBITDA0.08
EV / EBIT0.08
Revenue, mln0.00

Quote Details

Last 0.229
Change -0.2641 (-53.56%)
Open 0.498
Volume 2,433,094
Turnover 557,178
Average Volume 254,011

Financial Ratios

Pre-Tax Profit Margin-423,879
Leverage Ratio1.14
Current Ratio9.67
Price / Book0.21
Price / Tangible Book0.21
Price / Sales11.61

Financial Strength

Altman Z-Score-11.65
Piotroski F-Score 3 / 9
Beneish M-Score-36.58
1-Year Target Price3.30
Short Ratio2.03
Short % of Float3.90

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -44.98% 2 / 100   
1 Month -57.72% 4 / 100   
2 Months -66.81% 9 / 100   
6 Months -75.89% 8 / 100   
1 Year -80.92% 9 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog